目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T63711 | |||
Antifungal agent 43 是抗真菌剂,能够通过抑制生物膜的形成,表现出抗真菌效果。Antifungal agent 43 对人癌细胞株显示出低毒作用。 | |||
T62635 | |||
Antifungal agent 30 是一种有效的抗真菌剂。Antifungal agent 30 对白色念珠菌 (CPCC400616)(MIC: 0.03 μg/mL)和烟曲霉 (MIC: 0.5 μg/mL)表现出较好的抗真菌活性。Antifungal agent 30 对氟康唑耐药菌株也具有良好的抗真菌活性。Antifungal agent 30 的抗真菌活性主要是因为与 CYP51 的氢键和配位键相互作用。 | |||
T64029 | |||
Antifungal agent 42 是一种抗真菌剂,对生物膜形成具有抑制作用。Antifungal agent 42 能够抑制 C.alb.的 lanosterol 14α-demethylase (CYP51)。 | |||
T61308 | |||
Antifungal agent 27 (compound 7) is a chemical compound possessing antifungal properties. It exhibits moderate antibacterial activity and weak antifungal activity against MRSA and C. albicans SS5314, with minimal inhibitory concentration (MIC) values of 8 and 32 μg/mL, respectively [1]. | |||
T75176 | |||
Antifungal agent 53 (A03) 是一种有效的白色念珠菌 CYP51抑制剂,具有抗真菌活性。Antifungal agent 53 阻止真菌生物膜的形成。Antifungal agent 53 也显示出良好的安全性。 | |||
T63157 | |||
Antifungal agent 16 的抗菌活性与环丙沙星相当,且抗真菌活性高于氟康唑。 | |||
T61502 | |||
Antifungal agent 32 (compound 1a) is a highly effective antifungal compound. It displays strong inhibitory activity against Candida albicans filamentation and biofilm formation, as well as inhibiting the morphological switching of Candida albicans and its adherence to epithelial cells. This makes Antifungal agent 32 a valuable tool for research on Candida albicans infections [1]. | |||
T75179 | |||
Antifungal agent 56 (compound A09) 是一种抗氟康唑 耐药菌株的强效抗真菌剂。Antifungal agent 56 比咪康唑 更有效。Antifungal agent 56 抑制白色念珠菌的 MIC 值为 0.03-0.25 μg/mL。 | |||
T75178 | |||
Antifungal agent 55 (compound A07) 是一种抗氟康唑 耐药菌株的强效抗真菌剂。Antifungal agent 55 比咪康唑 更有效。Antifungal agent 55 抑制白色念珠菌的 MIC 值为 0.25-1 μg/mL。 | |||
T79545 | |||
Antifungalagent 66(compound 10)是一种具备广谱抗真菌活性的化合物。它对七种植物病原真菌菌丝体显示出有效抑制作用,并对B. cinerea孢子表现出显著的抑制活性,其IC50为47.7 μg/mL。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPH-00121 | Antifungal Protein, Aspergillus giganteus, Recombinant (B2M & His) | Aspergillus giganteus | E. coli | ||
This protein inhibits the growth of a variety of fungal species. Antifungal Protein, Aspergillus giganteus, Recombinant (B2M & His) is expressed in E. coli expression system with N-6xHis-B2M tag. The predicted molecular weight is 19.8 kDa and the accession number is P17737.
|
|||||
TMPH-03231 | AFP2 Protein, Raphanus sativus, Recombinant (His & SUMO) | Raphanus sativus | E. coli | ||
Possesses antifungal activity sensitive to inorganic cations. Induces potential changes in fungal membranes and increased K(+) efflux and Ca(2+) uptake. AFP2 Protein, Raphanus sativus, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 21.7 kDa and the accession number is P30230.
|
|||||
TMPH-02468 | Mo-CBP3 Protein, Moringa oleifera, Recombinant (GST) | Moringa oleifera | E. coli | ||
Chitin-binding protein. Has antifungal activity against F.solani, F.oxysporum, C.musae and C.gloesporoides but not against P.oligandrum. Depending on concentration the antifungal activity can be fungistatic or fungicidal. Inhibits both spore germination and mycelial growth in F.solani at a concentration of 0.1 mg/ml. Has antifungal activity against C.krusei, C.albicans, C.tropicalis and C.parapsilosis. Has no chitinase, beta-glucanase or hemagglutinating activity. Acts as a flocculent. Mo-CBP3 Protein, Moringa oleifera, Recombinant (GST) is expressed in E. coli expression system with N-GST tag. The predicted molecular weight is 29.2 kDa and the accession number is P86528.
|
|||||
TMPH-03060 | NaD1 Protein, Nicotiana alata, Recombinant (His & SUMO) | Nicotiana alata | E. coli | ||
Plant defense peptide with antifungal activity against F.oxysporum and B.cinerea. Retards the growth of the Lepidopteran insect pests H.armigera and H.punctigera.
|
|||||
TMPH-00027 | Aculeacin-A acylase Protein, Actinoplanes utahensis, Recombinant (His & SUMO) | Actinoplanes utahensis | E. coli | ||
Catalyzes the hydrolysis of the palmitoyl moiety of the antifungal antibiotic, aculeacin-A, giving a hexapeptide moiety and a long chain fatty acid. Aculeacin-A acylase Protein, Actinoplanes utahensis, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 35.1 kDa and the accession number is P29958.
|
|||||
TMPK-01308 | TAG-72 Protein, Canine, Recombinant (His) | Canine | E. coli | ||
The guanine-N7 methyltransferase domain of vaccinia virus mRNA capping enzyme is a heterodimer composed of a catalytic subunit and a stimulatory subunit. Cap (guanine-N7) methylation is an essential step in eukaryal mRNA synthesis and a potential target for antiviral, antifungal, and antiprotozoal drug discovery.
|
|||||
TMPH-00064 | MRJP1 Protein, Apis mellifera, Recombinant (His) | Apis mellifera | P. pastoris (Yeast) | ||
Induces the differentiation of honeybee larvae into queens through an Egfr-mediated signaling pathway. Promotes body size increase by activating p70 S6 kinase, stimulates ovary development by augmenting the titer of vitellogenin (Vg) and juvenile hormone, and reduces developmental time by increasing the activity of mitogen-activated protein kinase and inducing the 20-hydroxyecdysone protein (20E). Most abundant protein found in the royal jelly which is the food of the queen honey bee larva. The royal jelly determines the development of the young larvae and is responsible for the high reproductive ability of the honeybee queen.; Has antibacterial activity against the Gram-positive bacteria S.aureus ATCC 6535, S.saprophyticus and B.subtilis CCT2471, and the Gram-negative bacteria E.coli CCT1371, E.cloacae ATCC 23355, K.pneumoniae ATCC 13883 and P.aeruginosa ATCC 27853, and antifungal activity against C.albicans. Lack cytolytic activity and does not induce rat peritoneal mast cell degranulation.; Has antibacterial activity against the Gram-positive bacteria S.aureus ATCC 6535, S.saprophyticus and B.subtilis CCT2471, and the Gram-negative bacteria E.coli CCT1371, E.cloacae ATCC 23355, K.pneumoniae ATCC 13883 and P.aeruginosa ATCC 27853, and antifungal activity against C.albicans. Lack cytolytic activity and does not induce rat peritoneal mast cell degranulation.; Lacks antibacterial and antifungal activity. Lacks cytolytic activity and does not induce rat peritoneal mast cell degranulation.
|
|||||
TMPJ-00860 | HTN3 Protein, Human, Recombinant | Human | E. coli | ||
HTN3 belongs to the histatin/statherin family. Histatins are salivary proteins that are considered to be major precursors of the protective proteinaceous structure on tooth surfaces (enamel pellicle). In addition, histatins exhibit antibacterial and antifungal activities. Post-translational proteolytic processing results in many histatins: e.g., histatins 4-6 are derived from histatin 3 by proteolysis. Histatins 1 and 3 are primary products of HIS1and HIS2 alleles, respectively. Histatins are believed to have important non-immunological, anti-microbial function in the oral cavity.
|
|||||
TMPH-01001 | BCL10 Protein, Human, Recombinant (His & SUMO) | Human | E. coli | ||
Plays a key role in both adaptive and innate immune signaling by bridging CARD domain-containing proteins to immune activation. Acts by channeling adaptive and innate immune signaling downstream of CARD domain-containing proteins CARD9, CARD11 and CARD14 to activate NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines. Recruited by activated CARD domain-containing proteins: homooligomerized CARD domain-containing proteins form a nucleating helical template that recruits BCL10 via CARD-CARD interaction, thereby promoting polymerization of BCL10, subsequent recruitment of MALT1 and formation of a CBM complex. This leads to activation of NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines. Activated by CARD9 downstream of C-type lectin receptors; CARD9-mediated signals are essential for antifungal immunity. Activated by CARD11 downstream of T-cell receptor (TCR) and B-cell receptor (BCR). Promotes apoptosis, pro-caspase-9 maturation and activation of NF-kappa-B via NIK and IKK.
|